Def
Prevalência
Complicações
o respiratory distress syndrome o intraventricular hemorrhage o necrotizing enterocolitis o sepsis o neurologic impairment o seizures
Causas
FR
o Prior history of preterm birth o Preterm uterine contractions o Premature preterm rupture of membranes o Behavorial risk factors . Low maternal prepregnancy weight . Smoking . Substance abuse . Short interpregnancy interval o Current pregnancy factors . Short cervical lenght . Multifetal gestation . Vaginal bleeding . Urinary tract infections . Genital tract infections . Periodontal disease
DX
- ECO o Assessing gestational age of the fetus o Amniotic fluid volume o Fetal presentation o Placental location o Lenght of the cervix ( <28 s ) - entre o orifício interno e externo - quando inf a 25 mm temos risco elevado de ter parto antes das 34 sem
Gestão
o Corticosteroids (reduce the incidence and severity of fetal respiratory distress syndrome , the intraventricular hemorrhage and the necrotizing enterocolitis
. 24 – 34 weeks of gestation ( betamethasone/ dexamethasone)
. single course
. maximal benefit : next 7 days period
o Tocolytics (allows enough time of corticosteroid terapy to accelerate fetal lung maturation (48H) and maternal transport to a tertiary center . Calcium-channel blockers ( nifedipine) ->prevents calcium entry into muscle cells; EA: Maternal side effects : dizziness, flushing, hipotension and elevation of hepatic transaminases; Fetal or Newborn adverse effects : not know ; CI: hipotension, cardiac failure and aortic insufficience -> são as mais utilizadas
. Nonsteroidal anti-inflammatory drugs-> indometacina -> decreases Pg production; EA mãe: nausea, esophageal reflux, gastritis; feto: constriction of ductus arteriousus, oligohydramnios; CI: platelet dysfunction bleeding, hepatic dysfunction -> Importante abaixo das 32/28 sem (NÃO DEVE SER USADO ACIMA DAS 32 SEMANAS)
. β-Adrenergic receptor agonists
. Antagonists of oxytocin receptor -> atosiban -> EA mãe/feto: desconhecidos a presença-> unica que foi desenhada para ser tocolítico (abaixo ds 28 sem eficacia inf a indometacina, EV, custo superior)
o Neuroprotection-> Magnesium sulfate (24 -32w) : lower the risk of developing cerebral palsy
CI a tocolise
o Intrauterine fetal demise o Lethal fetal anomaly o Non reassuring fetal status o Severe preeclampsia or eclampsia o Maternal bleeding with hemodynamic instability o Intra-amniotic infection o PPROM o Maternal contraindication to tocolysis
Prevenção
o Spontaneous ( 40 a 50% PTB with intact membranes; 25 a 30% from PPROM)
o Indicated ( 20 a 30% )
- Prevenção primária (FR): o early detection and treatment of UTI o weight gain during pregnancy o healthy life style ( stop smoking) o lower multiple pregnancy